Drug Shortage Report for ETOPOSIDE INJECTION

Last updated on 2020-03-16 History
Report ID 68629
Drug Identification Number 02080036
Brand name ETOPOSIDE INJECTION
Common or Proper name ETOPOSIDE
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ETOPOSIDE
Strength(s) 20MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 50ML
ATC code L01CB
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-04
Estimated end date 2020-03-31
Actual end date 2020-03-15
Shortage status Resolved
Updated date 2020-03-16
Company comments Allocating Inventory until next supply (3/31) for 100% of Market.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v34 2020-03-16 French Compare
v33 2020-03-16 English Compare
v32 2019-11-28 French Compare
v31 2019-11-28 English Compare
v30 2019-11-28 English Compare
v29 2019-11-28 French Compare
v28 2019-11-28 English Compare
v27 2019-11-21 French Compare
v26 2019-11-21 English Compare
v25 2019-10-24 French Compare
v24 2019-10-24 English Compare
v23 2019-10-17 French Compare
v22 2019-10-17 English Compare
v21 2019-10-03 French Compare
v20 2019-10-03 English Compare
v19 2019-09-19 French Compare
v18 2019-09-19 English Compare
v17 2019-09-04 French Compare
v16 2019-09-04 English Compare
v15 2019-08-29 French Compare

Showing 1 to 20 of 34